Quality of life, anxiety and depression in patients with androgenetic alopecia

Simple item page
dc.contributor.authorBilaç C.
dc.contributor.authorÖztürkcan S.
dc.contributor.authorSahin M.T.
dc.contributor.authorKutlubay Z.
dc.contributor.authorSerdaroglu S.
dc.contributor.authorYasar A.
dc.contributor.authorDinç G.
dc.date.accessioned2024-07-22T08:06:12Z
dc.date.available2024-07-22T08:06:12Z
dc.date.issued2021
dc.description.abstractBackground: Androgenetic alopecia (AGA) is a common form of hair loss, which can result in body image disorder and negative social feelings. Aim: The aim of this study was to evaluate the quality of life (QoL) and the risk of anxiety and depression in AGA patients. Method: Sociodemographic data of the patients and clinical severity of the disease were recorded. The QoL score of patient and controls was evaluated with DLQI and SF-36 instruments, their anxiety and depression risks were evaluated with HAD (HAD-A and HAD-D) instruments. Results: Sixty-eight patients with AGA were included in our study. Young male AGA patients' quality of life levels were found to be low according to role limitations due to emotional problems, emotional well-being and emotional scores of SF-36 scale and younger female AGA patients quality of life levels were also found to be low according to role limitations due to emotional problems, and emotional scores of SF-36 scale. The DLQI scores of patients of both sex were found to be sig nificantly higher compared to control group. According to anxiety and depression risk assessment with HAD scale, it was found that 28.6% and 73.5% of patients were prone to suffer from anxiety and depression respectively. Conclusion: Apart from managing alopecia, practitioners should be aware of the possible psychosocial distress of AGA patients and manage accordingly. © 2021 Medcom Limited. All rights reserved.
dc.identifier.issn18147453
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13424
dc.language.isoEnglish
dc.publisherMedcom Limited
dc.subjectadult
dc.subjectaged
dc.subjectanxiety
dc.subjectanxiety disorder
dc.subjectArticle
dc.subjectchronic disease
dc.subjectclinical feature
dc.subjectcomparative study
dc.subjectcontrolled study
dc.subjectdepression
dc.subjectDermatology Life Quality Index
dc.subjectdisease severity
dc.subjecteducational status
dc.subjectemotional well-being
dc.subjectfemale
dc.subjectHospital Anxiety and Depression Scale
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmale type alopecia
dc.subjectmarriage
dc.subjectpsychological well-being
dc.subjectquality of life
dc.subjectrisk assessment
dc.subjectShort Form 36
dc.subjectsocial interaction
dc.subjectstudent
dc.subjectunemployment
dc.titleQuality of life, anxiety and depression in patients with androgenetic alopecia
dc.typeArticle

Files

Collections

Scopus Koleksiyonu